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Background: Cardiomyocytes (CMs) and mesenchymal stem cells (MSCs) are the founding cell types for cardiomyogenesis and angiogenesis, 
respectively. Currently, CMs and MSCs may be separately generated from human induced pluripotent stem cells (hiPSCs) in a cumbersome multi-step 
procedure. We simultaneous generated both CMs and MSCs from hiPSCs via a pro-mesoderm differentiation strategy.
Methods: Two hiPSC lines were reprogrammed from human dermal fibroblasts via retroviral-transduction and their pluripotency was confirmed by 
RT-PCR, immunocytochemistry and teratoma formation assay. Embryoid bodies (EBs) were formed and cardiac differentiated in a serum-free and 
insulin-depleted medium containing a p-38 MAPK inhibitor, SB 203580. CMs were isolated from dissected contractile EB outgrowths and MSCs were 
subsequently established from the remaining stromal cells.
Results: CMs and MSCs were repeatedly co-generated from contracting EB aggregates. Comparing to a conventional EB20 method of using 20% 
fetal bovine serum, the CARM/SB method achieved similar cardiac differentiation efficiency (25-30%) with equivalent cardiac gene expression 
and comparable population of cardiac subtypes. However, homogenous MSCs were only generated with the CARM/SB, but not the EB20 method. 
The iPSC-MSCs expressed common MSC markers (CD29, CD44, CD73, CD90, CD105 and CD146) and were capable of adipogenic and osteogenic 
differentiation. They were free of contaminating iPSCs as evidence by lack of hESC markers expression and no teratoma formation in SCID mice. 
Comparing to bone marrow-derived MSCs, hiPSC-MSCs expressed higher telomerase activity and could be rapidly expanded in culture (> passage 
20) without sign of senescence. Moreover, hiPSC-MSCs showed superior pro-angiogenic and migratory activity by Matrigel-based endothelial tube 
formation and fibroblasts wound healing assays.
Conclusions: We developed an expedited strategy to simultaneously generate CMs and large quantity of homogenous MSCs in a simple, low-cost 
and efficient manner. Functional and biological compatible CMs and MSCs co-generated from patient-specific hiPSCs could be collectively adopted 
for autologous cardiac repair.
